Skip to main content
SpringerLink
Log in

Epidemiology of Gastric Cancer

  • Chapter
  • First Online:
Gastric Cancer

Abstract

Gastric cancer is the third leading cause of cancer-related death worldwide. Despite a decrease in its incidence in some regions of the world, gastric cancer still poses a major clinical challenge because most cases are diagnosed in an advanced stage, with a poor prognosis and limited treatment options. The most common causes are Helicobacter pylori infection (proven), Epstein-Barr virus infection (suspected), and familial. Major predisposing factors include high salt intake, smoking, and a familial genetic component. Primary prevention (i.e., H. pylori eradication) is increasingly recommended. Despite a growing understanding of both the phenotypic alterations and the molecular mechanisms occurring during gastric cancer carcinogenesis, no reliable biomarkers are available as yet for use in gastric cancer secondary prevention strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Parkin DM. The global health burden of infectionassociated cancers in the year 2002. Int J Cancer. 2006;118:3030–44.

    Article  CAS  PubMed  Google Scholar 

  2. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    Article  PubMed  Google Scholar 

  3. Hanada K, Graham DY. Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma. Expert Rev Anticancer Ther. 2014;14:947–54.

    Article  CAS  PubMed  Google Scholar 

  4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  5. Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013;107:230–6.

    Article  PubMed  Google Scholar 

  6. Bria E, De Manzoni G, Beghelli S, Tomezzoli A, Barbi S, et al. A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status. Ann Oncol. 2013;24:693–701.

    Article  CAS  PubMed  Google Scholar 

  7. Yamamoto H, Watanabe Y, Maehata T, Morita R, Yoshida Y, et al. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa. World J Gastroenterol. 2014;20:3927–37.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Correa P. Gastric cancer: overview. Gastroenterol Clin North Am. 2013;42:211–7.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Bosman FT, World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer; 2010. 417 p.

    Google Scholar 

  10. Santoro E. The history of gastric cancer: legends and chronicles. Gastric Cancer. 2005;8:71–4.

    Article  PubMed  Google Scholar 

  11. Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol. 2010;45:1–8.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Gray H, Balfour D. Cancer of the stomach. Am J Cancer. 1934;22:249–86.

    Google Scholar 

  13. Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014;20:5191–204.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Faber K. Chronic gastritis: its relation to achylia and ulcer. Lancet. 1927;2:902–7.

    Google Scholar 

  15. Comfort MW. Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance. Ann Intern Med. 1951;34:1331–1348.

    Article  CAS  PubMed  Google Scholar 

  16. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet. 1975;2:58–60.

    Article  CAS  PubMed  Google Scholar 

  17. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273–5.

    Google Scholar 

  18. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–5.

    Article  CAS  PubMed  Google Scholar 

  19. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, et al. Gastritis: the histology report. Dig Liver Dis. 2011;43(Suppl 4):S373–84.

    Article  PubMed  Google Scholar 

  20. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.

    CAS  PubMed  Google Scholar 

  21. Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128:765–70.

    PubMed  Google Scholar 

  22. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.

    Article  Google Scholar 

  23. The Cancer Genome Atlas Research N, Analysis Working Group: Dana-Farber Cancer I, Institute for Systems B, University of Southern C, Memorial Sloan Kettering Cancer C, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.

    Article  Google Scholar 

  24. Wang K, Yuen ST, Xu J, Lee SP, Yan HH, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46:573–82.

    Article  CAS  PubMed  Google Scholar 

  25. Kakiuchi M, Nishizawa T, Ueda H, Gotoh K, Tanaka A, et al. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat Genet. 2014;46:583–7.

    Article  CAS  PubMed  Google Scholar 

  26. Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med. 2001;344:1904–9.

    Article  CAS  PubMed  Google Scholar 

  27. Pizzi M, Saraggi D, Fassan M, Megraud F, Di Mario F, et al. Secondary prevention of epidemic gastric cancer in the model of Helicobacter pylori-associated gastritis. Dig Dis. 2014;32:265–74.

    Article  PubMed  Google Scholar 

  28. Rugge M, Fassan M, Graham DY. Clinical guidelines: secondary prevention of gastric cancer. Nat Rev Gastroenterol Hepatol. 2012;9:128–9.

    Article  PubMed  Google Scholar 

  29. Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, et al. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics. 2013;14:589.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. Geneva: The Agency: Secretariat of the World Health Organization Distributor; 1994. 270 p.

    Google Scholar 

  31. Helicobacter, Cancer Collaborative G. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49:347–53.

    Article  Google Scholar 

  32. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136:1863–73.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Shiotani A, Cen P, Graham DY. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol. 2013;23:492–501.

    Article  CAS  PubMed  Google Scholar 

  34. Delahay RM, Rugge M. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2012;17(Suppl 1):9–15.

    Article  CAS  PubMed  Google Scholar 

  35. Holcombe C. Helicobacter pylori: the African enigma. Gut. 1992;33:429–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Akiba S, Koriyama C, Herrera-Goepfert R, Eizuru Y. Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci. 2008;99:195–201.

    Article  CAS  PubMed  Google Scholar 

  37. Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009;137:824–33.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci. 2005;96:1–6.

    Article  CAS  PubMed  Google Scholar 

  39. Jakszyn P, Gonzalez CA. Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol. 2006;12:4296–303.

    CAS  PubMed Central  PubMed  Google Scholar 

  40. Gonzalez CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. Int J Cancer. 2012;130:745–53.

    Article  CAS  PubMed  Google Scholar 

  41. Gonzalez CA, Pera G, Agudo A, Palli D, Krogh V, et al. Smoking and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2003;107:629–34.

    Article  CAS  PubMed  Google Scholar 

  42. Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V. Alcohol consumption, smoking and risk of gastric cancer: case-control study from Moscow, Russia. Cancer Causes Control. 2000;11:363–71.

    Article  CAS  PubMed  Google Scholar 

  43. Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, et al. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol. 2012;23:28–36.

    Article  CAS  PubMed  Google Scholar 

  44. Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, et al. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest. 2013;123:479–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Larsson SC, Bergkvist L, Wolk A. Fruit and vegetable consumption and incidence of gastric cancer: a prospective study. Cancer Epidemiol Biomarkers Prev. 2006;15:1998–2001.

    Article  PubMed  Google Scholar 

  46. Plummer M, Vivas J, Lopez G, Bravo JC, Peraza S, et al. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population. J Natl Cancer Inst. 2007;99:137–46.

    Article  CAS  PubMed  Google Scholar 

  47. You WC, Blot WJ, Chang YS, Ershow AG, Yang ZT, et al. Diet and high risk of stomach cancer in Shandong, China. Cancer Res. 1988;48:3518–23.

    CAS  PubMed  Google Scholar 

  48. You WC, Brown LM, Zhang L, Li JY, Jin ML, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98:974–83.

    Article  PubMed  Google Scholar 

  49. Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol. 2006;14:21–33.

    Article  CAS  PubMed  Google Scholar 

  50. Fassan M, Baffa R, Kiss A. Advanced precancerous lesions within the GI tract: the molecular background. Best Pract Res Clin Gastroenterol. 2013;27:159–69.

    Article  CAS  PubMed  Google Scholar 

  51. Tsukanov VV, Butorin NN, Maady AS, Shtygasheva OV, Amelchugova OS, et al. Helicobacter pylori infection, intestinal metaplasia, and gastric cancer risk in Eastern Siberia. Helicobacter. 2011;16:107–12.

    Article  PubMed  Google Scholar 

  52. Naess O, Strand BH, Smith GD. Childhood and adulthood socioeconomic position across 20 causes of death: a prospective cohort study of 800,000 Norwegian men and women. J Epidemiol Community Health. 2007;61:1004–9.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Nagel G, Linseisen J, Boshuizen HC, Pera G, Del Giudice G, et al. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Epidemiol. 2007;36:66–76.

    Article  PubMed  Google Scholar 

  54. Shimizu H, Mack TM, Ross RK, Henderson BE. Cancer of the gastrointestinal tract among Japanese and White immigrants in Los Angeles County. J Natl Cancer Inst. 1987;78:223–8.

    CAS  PubMed  Google Scholar 

  55. Lee J, Demissie K, Lu SE, Rhoads GG. Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control. 2007;14:78–85.

    PubMed  Google Scholar 

  56. Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303:1723–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am. 2002;11:235–56.

    Article  PubMed  Google Scholar 

  58. Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol. 2013;23:3–9.

    Article  PubMed Central  PubMed  Google Scholar 

  59. Rugge M, Fassan M, Cavallin F, Zaninotto G. Re: risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2012;104:1771–2.

    Article  PubMed  Google Scholar 

  60. Rugge M, Zaninotto G, Parente P, Zanatta L, Cavallin F, et al. Barrett’s esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA). Ann Surg. 2012;256:788–94; discussion 794–785.

    Article  PubMed  Google Scholar 

  61. Bornschein J, Leja M, Kupcinskas J, Link A, Weaver J, et al. Molecular diagnostics in gastric cancer. Front Biosci (Landmark Ed). 2014;19:312–38.

    Article  CAS  Google Scholar 

  62. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44:74–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  63. Bornschein J, Kandulski A, Selgrad M, Malfertheiner P. From gastric inflammation to gastric cancer. Dig Dis. 2010;28:609–14.

    Article  PubMed  Google Scholar 

  64. Fassan M, Croce CM, Rugge M. miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol. 2011;17:5231–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  65. Fassan M, Simbolo M, Bria E, Mafficini A, Pilotto S, et al. High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers. Gastric Cancer. 2014;17:442–9.

    Article  PubMed  Google Scholar 

  66. Wang K, Kan J, Yuen ST, Shi ST, Chu KM, et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet. 2011;43:1219–23.

    Article  CAS  PubMed  Google Scholar 

  67. Zang ZJ, Cutcutache I, Poon SL, Zhang SL, McPherson JR, et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet. 2012;44:570–4.

    Article  CAS  PubMed  Google Scholar 

  68. Weissman B, Knudsen KE. Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. Cancer Res. 2009;69:8223–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  69. Dong B, Xie YQ, Chen K, Wang T, Tang W, et al. Differences in biological features of gastric dysplasia, indefinite dysplasia, reactive hyperplasia and discriminant analysis of these lesions. World J Gastroenterol. 2005;11:3595–600.

    Article  PubMed Central  PubMed  Google Scholar 

  70. Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, et al. Epigenetic mechanisms in gastric cancer. Epigenomics. 2012;4:279–94.

    Article  CAS  PubMed  Google Scholar 

  71. Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, et al. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol. 2009;40:1534–42.

    Article  CAS  PubMed  Google Scholar 

  72. Lu XX, Yu JL, Ying LS, Han J, Wang S, et al. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Cancer. 2012;118:5507–17.

    Article  CAS  PubMed  Google Scholar 

  73. Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int. 2010;60:337–50.

    Article  CAS  PubMed  Google Scholar 

  74. Compare D, Rocco A, Liguori E, D’Armiento FP, Persico G, et al. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis. J Clin Pathol. 2011;64:677–82.

    Article  PubMed  Google Scholar 

  75. Zheng Z, Andersson AF, Ye W, Nyren O, Normark S, et al. A method for metagenomics of Helicobacter pylori from archived formalin-fixed gastric biopsies permitting longitudinal studies of carcinogenic risk. PLoS ONE. 2011;6:e26442.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  76. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010;11:136–46.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  77. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  78. Rugge M, Capelle LG, Cappellesso R, Nitti D, Kuipers EJ. Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol. 2013;27:205–23.

    Article  PubMed  Google Scholar 

  79. Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol. 2000;24:167–76.

    Article  CAS  PubMed  Google Scholar 

  80. Correa P, Piazuelo MB. Natural history of Helicobacter pylori infection. Dig Liver Dis. 2008;40:490–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  81. Fassan M, Pizzi M, Farinati F, Nitti D, Zagonel V, et al. Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. Am J Clin Pathol. 2012;137:727–32.

    Article  PubMed  Google Scholar 

  82. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.

    Article  CAS  PubMed  Google Scholar 

  83. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol. 1991;6:209–22.

    Article  CAS  PubMed  Google Scholar 

  84. Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol. 2005;36:228–33.

    Article  PubMed  Google Scholar 

  85. Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71:1150–8.

    Article  PubMed  Google Scholar 

  86. Rugge M, Genta RM, Group O. Staging gastritis: an international proposal. Gastroenterology. 2005;129:1807–8.

    Article  PubMed  Google Scholar 

  87. Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010;31:1104–11.

    CAS  PubMed  Google Scholar 

  88. Daugule I, Sudraba A, Chiu HM, Funka K, Ivanauskas A, et al. Gastric plasma biomarkers and operative link for gastritis assessment gastritis stage. Eur J Gastroenterol Hepatol. 2011;23:302–7.

    Article  CAS  PubMed  Google Scholar 

  89. Rugge M, Fassan M, Pizzi M, Farinati F, Sturniolo GC, et al. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol. 2011;17:4596–601.

    Article  PubMed Central  PubMed  Google Scholar 

  90. den Hoed CM, Holster IL, Capelle LG, de Vries AC, den Hartog B, et al. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. Endoscopy. 2013;45:249–56.

    Article  CAS  PubMed  Google Scholar 

  91. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, et al. Management of Helicobacter pylori infection—the Maastricht IV/Florence Consensus Report. Gut. 2012;61:646–64.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine (DIMED), Pathology, University of Padua, Via Aristide Gabelli, 61, 35121, Padua, Italy

    Massimo Rugge MD, FAC, G

  2. Department of Medicine (DIMED), Pathology, University of Padua, Padua, Italy

    Matteo Fassan MD, PhD

  3. Department of Medicine, Michael E. DeBakey VA Medical Center, Holcombe Blvd, 2002, Houston, TX, USA

    David Y. Graham MD

Authors
  1. Massimo Rugge MD, FAC, G
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matteo Fassan MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Y. Graham MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Rugge MD, FAC, G .

Editor information

Editors and Affiliations

  1. Gastric and Mixed Tumor Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Vivian E. Strong

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rugge, M., Fassan, M., Graham, D. (2015). Epidemiology of Gastric Cancer. In: Strong, V. (eds) Gastric Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-15826-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15826-6_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15825-9

  • Online ISBN: 978-3-319-15826-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation